Chang et al. Science, vol. 267, pp. 518-522, Jan. 1995.* |
Steg et al. Circulation, vol. 90, pp. 1648-1656, 1994.* |
Barron, L.G. et al., “Cationic Lipids Are Essential For Gene Delivery Mediated By Intravenous Administration Of Lipoplexes.” Gene Therapy 1999; 6, 1179-1183. |
Feldman, L. et al., “Low-Efficiencyof Percutaneous Adenovirus-Mediated Arterial Gene Transfer In The Atherosclerotic Rabbit,” J. Clinical Investigation 1995; 95:2622-2671. |
Lew, D. et al., “Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice,” Human Gene Therapy 1995; 6:553-564. |
Newman, K. et al., “Adenovirus-Mediated Gene Transfer Into Normal Rabbit Arteries Results In Prolonged Vascular Cell Activation, Inflammation, And Neointimal Hyperplasia,” J. Clinical Investigation 1995; 96:2955-2965. |
Stephan, D. et al., “A New Cationic Liposome DNA Complex Enhances The Efficiency Of Arterial Gene Transfer In Vivo,” Human Gene Therapy 1996; 7:1803-1812. |
Barron, L.G. et al., “Cationic Lipids Are Essential For Gene Delivery Mediated By Intravenous Administration Of Lipoplexes.” Gene Therapy 1999; 6, 1179-1183. |
Acsadi, G. et al., “Direct Gene Transfer and Expression into Rat Heart in Vivo” The New Biologist; vol. 3, No. 1 (January Intitative Evaluation of Liver-Specific R991) pp. 71-81. |
Barr, E. et al., “Efficient Catheter-mediated Gene Transfer into the Heart using Replication-defective Adenovirus.” Gene Therapy 1994; 1; 51-58. |
Bowling, W.M., et al., “Portal Branch Occlusion Safely Facilitates In Vivo Retroviral Vector Transduction of Rat Liver”Human Gene Therapy 7; pp. 2113-2121 (Nov. 10, 1996). |
Branchereau, S., et al., “Factors Influencing Retroviral-Mediated Gene Transfer into Hepatocytes In Vivo” Human Gene Therapy 5; pp. 803-808, (1994). |
Gal, D. et al., “Direct Myocardial Transfection In Two Animal Models: Evaluation of Parameters Affecting Gene Expression and Percutaneous Gene Delivery.” Laboratory Investigation; vol. 68, No. 1, p. 18, 1993. |
Gilgenkrantz, H., et al., “Transient Expression of Genes Transferred In Vivo into Heart Using First-Generation Adenoviral Vectors: Role of the Immune Response.” Human Gene Therapy 6; pp. 1265-1274 (Oct. 1995). |
Hafenrichter, D.G. et al., “Liver-Directed Gene Therapy: Evaluation of Liver Specific Promoter Elements” Journal of Surgical Research 56; 510-517 (1994). |
Hafenrichter, D.G. et al., “Optimization of Liver-Directed Retroviral Gene Delivery.” Transplantation Proceedings; vol. 26, No. 6 (Dec.), 1994; pp. 3379-3780. |
Hafenrichter, D.G. et al., “Quantitative Promoters From Retroviral Vectors After In Vivo Transduction of Hepatocytes” Blood; vol. 84, No. 10 (Nov. 15), 1994: pp. 3394-3404. |
Kolodka, T.M. et al., “Hepatic Gene Therapy: Efficient Retroviral-Mediated Gene Transfer into Rat Hepatocytes In Vivo” Somatic Cell and Molecular Genetics; vol. 19, No. 5, 1993, pp. 491-497. |
Lemarchand, P. et al., “In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery” Adenovirus Gene Therapy via the Pulmonary Circulation; pp. 2840-2845.ne Response. |
Lin, H. et al., “Expression of Recombinant Genes in Myocardium In Vivo After Direct Injection of DNA” Circulation; vol. 82, No. 6, Dec. 1990, pp. 2217-2220. |
Lu, X. et al., “Antisense DNA Delivery In Vivo: Liver Targeting by Receptor-Mediated Uptake” The Journal of Nuclear Medicine; vol. 35, No. 2, Feb. 1994, pp. 269-275. |
Muhlhauser, J., et al., “In Vivo Angiogenesis Induced by Recombinant Adenovirus Vectors Coding Either for Secreted of Nonsecreted Forms of Acidic Fibroblast Growth Factor” Human Gene Therapy 6; pp. 1457-1465 (Nov. 1995). |
Nabel, E.G., et al., “Safety and Toxicity of Catheter Gene Delivery to the Pulmonary Vasculature in a Patient with Metastatic Melanoma” Human Gene Therapy 5; pp. 1089-1094, (1994). |
Ponder, K.P., et al., “Evaluation of Relative Promoter Strength in Primary Hepatocytes Using Optimized Lipofection” Human Gene Therapy 2; pp. 41-52 (1991). |
Rettinger, S.D. et al., “In Vivo Hepatocyte Transduction with Retrovirus during In-flow Occlusion” Journal of Surgical Research 54; 418-425 (1993). |
Rettinger, S.D. et al., “Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction.” Proc. Natl. Acad. Sci. USA; vol. 91, pp. 1460-1464, Feb. 1994. |
Schachtner, S.K et al., “In Vivo Adenovirus-Mediated Gene Transfer Via the Pulmonary Artery of Rats” Circulation Research; vol. 76, No. 5, May 1995, pp. 701-709. |
Shi, Y. et al., “Transgene Expression in the Coronary Circulation: Transcatheter Gene Delivery.” Gene Therapy 1994; 1; 404-414. |
Soriano P. et al., “Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene.” Proc. Matl. Acad. Sci. USA; vol. 80, pp. 7128-7131, Dec. 1983. |
von Harsdorf, R. et al., “Gene Infection Into Canine Myocardium as a Useful Model for Studying Gene Expression in the Heart of Large Mammals” Gene Expression in the Heart; pp. 88-695. |